1 study found for:    19228742 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: BAY 43-9006

Indicates status has not been verified in more than two years